Reslizumab

Refrigerated StorageLactation Safety InformationNew Medicines ·
Unassigned

Refrigerated Storage

Cinqaero Teva

Teva
Cinqaero
Concentrate for solution for infusion

The manufacturer does not hold stability data in addition to that provided in the Summary of Product Characteristics (SPC).

Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Do not freeze.

Keep the vial in the outer carton in order to protect from light.

13 October 2020
London MI Service

Lactation Safety Information

Corticosteroids
Monoclonal antibody used for refractory eosinophilic asthma
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties and likely to be degraded in infant’s GI tract, although long half-life increases risk of accumulation in breastfed infant
Although large protein molecules may appear in colostrum, risk to preterm infants and neonates is considered to be small and unproven
21 April 2017

New Medicines

Cinqaero (EU), Cinqair (US)Severe eosinophilic asthma - subcutaneous formulation

Information

Cinqaero (EU), Cinqair (US)
New formulation
Teva
Teva

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Anti-interleukin-5 monoclonal antibody; subcutaneous formulation
At least 1 in 10 children and 1 in 20 adults have asthma.
Severe eosinophilic asthma - subcutaneous formulation
Subcutaneous